Literature DB >> 16880523

Genetic analysis of myc and telomerase interactions in vivo.

Ignacio Flores1, Gerard Evan, María A Blasco.   

Abstract

Myc is a transcription factor with pleiotropic effects on tumorigenesis which are likely to be mediated by its target genes. A known Myc transcriptional target is the catalytic subunit of telomerase, Tert. However, the contribution of Tert activation to Myc-induced tumorigenesis in vivo remains unknown. In this study, we addressed the role of telomerase in Myc-induced skin papillomatosis by using compound mice with a switchable Myc gene, Inv-MycERTAM mice, in combination with either telomerase deficiency (Terc-/-) or telomerase overexpression (K5-mTert) in the skin. We first demonstrated that Myc activates telomerase in the skin. With Inv-MycERTAM x Terc-/- mice, we further showed that this telomerase activation is partially required to elicit a full hyperplastic Myc-induced response. The presence of critically short telomeres in late-generation Inv-MycERTAM x Terc-/- mice further reduced the skin lesion induced by Myc. On the other hand, telomerase overexpression in the skin of K5-mTert mice augments Myc-induced hyperplasia in the absence of changes in telomere length, suggesting a direct role of telomerase in the Myc protumorigenic response. Taken together, these results highlight telomerase as a mediator of Myc-induced papillomatosis and suggest telomerase as a putative therapeutic target for Myc-dependent lesions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880523      PMCID: PMC1592815          DOI: 10.1128/MCB.00543-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  Telomerase beyond telomeres.

Authors:  María A Blasco
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  c-Myc-mediated regulation of telomerase activity is disabled in immortalized cells.

Authors:  R Drissi; F Zindy; M F Roussel; J L Cleveland
Journal:  J Biol Chem       Date:  2001-06-11       Impact factor: 5.157

4.  Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes.

Authors:  E González-Suárez; E Samper; A Ramírez; J M Flores; J Martín-Caballero; J L Jorcano; M A Blasco
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT.

Authors:  S L Weinrich; R Pruzan; L Ma; M Ouellette; V M Tesmer; S E Holt; A G Bodnar; S Lichtsteiner; N W Kim; J B Trager; R D Taylor; R Carlos; W H Andrews; W E Wright; J W Shay; C B Harley; G B Morin
Journal:  Nat Genet       Date:  1997-12       Impact factor: 38.330

6.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Authors:  Laura L Smith; Hilary A Coller; James M Roberts
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

7.  Cooperation between p53 mutation and high telomerase transgenic expression in spontaneous cancer development.

Authors:  Eva González-Suárez; Juana M Flores; María A Blasco
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 8.  Cancer revoked: oncogenes as therapeutic targets.

Authors:  Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

Review 9.  c-MYC: more than just a matter of life and death.

Authors:  Stella Pelengaris; Mike Khan; Gerard Evan
Journal:  Nat Rev Cancer       Date:  2002-10       Impact factor: 60.716

Review 10.  Telomerase: a target for cancer therapeutics.

Authors:  Jerry W Shay; Woodring E Wright
Journal:  Cancer Cell       Date:  2002-10       Impact factor: 31.743

View more
  13 in total

1.  Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells.

Authors:  Fang Wang; Yu Yin; Xiaoying Ye; Kai Liu; Haiying Zhu; Lingling Wang; Maria Chiourea; Maja Okuka; Guangzhen Ji; Jiameng Dan; Bingfeng Zuo; Minshu Li; Qian Zhang; Na Liu; Lingyi Chen; Xinghua Pan; Sarantis Gagos; David L Keefe; Lin Liu
Journal:  Cell Res       Date:  2011-12-20       Impact factor: 25.617

2.  Saccharomyces cerevisiae as a model for the study of extranuclear functions of mammalian telomerase.

Authors:  Lucia Simonicova; Henrieta Dudekova; Jaroslav Ferenc; Katarina Prochazkova; Martina Nebohacova; Roman Dusinsky; Jozef Nosek; Lubomir Tomaska
Journal:  Curr Genet       Date:  2015-01-08       Impact factor: 3.886

3.  c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNA.

Authors:  Md Ashraful Islam; Shelia D Thomas; Vundavalli V Murty; Kara J Sedoris; Donald M Miller
Journal:  J Biol Chem       Date:  2014-01-24       Impact factor: 5.157

4.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.

Authors:  Cheryl M Koh; Ekta Khattar; Shi Chi Leow; Chia Yi Liu; Julius Muller; Wei Xia Ang; Yinghui Li; Guido Franzoso; Shang Li; Ernesto Guccione; Vinay Tergaonkar
Journal:  J Clin Invest       Date:  2015-04-20       Impact factor: 14.808

5.  PinX1 inhibits telomerase activity in gastric cancer cells through Mad1/c-Myc pathway.

Authors:  Hong-bin Wang; Xing-wei Wang; Gang Zhou; Wei-qiang Wang; Yong-gang Sun; Shi-ming Yang; Dian-chun Fang
Journal:  J Gastrointest Surg       Date:  2010-06-11       Impact factor: 3.452

Review 6.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Synthesis and antitumor mechanism of a new iron(iii) complex with 5,7-dichloro-2-methyl-8-quinolinol as ligands.

Authors:  Bi-Qun Zou; Qi-Pin Qin; Yu-Xia Bai; Qian-Qian Cao; Ye Zhang; Yan-Cheng Liu; Zhen-Feng Chen; Hong Liang
Journal:  Medchemcomm       Date:  2017-02-01       Impact factor: 3.597

8.  Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer.

Authors:  Bruno Bernardes de Jesus; Elsa Vera; Kerstin Schneeberger; Agueda M Tejera; Eduard Ayuso; Fatima Bosch; Maria A Blasco
Journal:  EMBO Mol Med       Date:  2012-05-15       Impact factor: 12.137

9.  SIRT1 is necessary for proficient telomere elongation and genomic stability of induced pluripotent stem cells.

Authors:  Maria Luigia De Bonis; Sagrario Ortega; Maria A Blasco
Journal:  Stem Cell Reports       Date:  2014-04-17       Impact factor: 7.765

Review 10.  MYC in mammalian epidermis: how can an oncogene stimulate differentiation?

Authors:  Fiona M Watt; Michaela Frye; Salvador Aznar Benitah
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.